mouse monoclonal anti il 1β antibody Search Results


tnf α  (Miltenyi Biotec)
90
Miltenyi Biotec tnf α
Lithium suppresses activation of inflammatory cytokines in the spinal cord of rats with SCI . Sham group: No spinal cord injury or treatment; SCI group: spinal cord injury only; LiCl group: lithium treatment after spinal cord injury. <t>(A–C)</t> <t>TNF-α</t> (A), IL-1β (B), and IL-6 (C) expression in the spinal cord were detected by enzyme-linked immunosorbent assay. (D) Representative immunohistochemical staining for IL-1β 7 days after surgery. The number of IL-1β-positive cells was higher in the LiCl group than in the sham group, but lower than in the SCI group. Black arrows indicate IL-1β-positive cells. Scale bars: 50 μm. (E) Quantification of IL-1β-positive cells 7 days after surgery. (F, <t>G)</t> <t>TNF-α,</t> IL-1β, and IL-6 expression. Data are shown as mean ± SD ( n = 6). * P < 0.05, vs . sham group; # P < 0.05, vs . SCI group (one-way analysis of variance followed by the least significant difference test). IL-1β: Interleukin-1β; IL-6: interleukin-6; LiCl: lithium chloride; SCI: spinal cord injury; TNF-α: tumor necrosis factor-alpha.
Tnf α, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+monoclonal+anti+il+1%CE%B2+antibody/IL-1%CE%B2+Pro-form+Antibody%2C+anti-mouse%2C+REAfinity/pmc08643056-113-34-36
Average 90 stars, based on 1 article reviews
tnf α - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
mouse il-1 beta/il-1f2 antibody  (Bio-Techne corporation)
93
Bio-Techne corporation mouse il-1 beta/il-1f2 antibody
Lithium suppresses activation of inflammatory cytokines in the spinal cord of rats with SCI . Sham group: No spinal cord injury or treatment; SCI group: spinal cord injury only; LiCl group: lithium treatment after spinal cord injury. <t>(A–C)</t> <t>TNF-α</t> (A), IL-1β (B), and IL-6 (C) expression in the spinal cord were detected by enzyme-linked immunosorbent assay. (D) Representative immunohistochemical staining for IL-1β 7 days after surgery. The number of IL-1β-positive cells was higher in the LiCl group than in the sham group, but lower than in the SCI group. Black arrows indicate IL-1β-positive cells. Scale bars: 50 μm. (E) Quantification of IL-1β-positive cells 7 days after surgery. (F, <t>G)</t> <t>TNF-α,</t> IL-1β, and IL-6 expression. Data are shown as mean ± SD ( n = 6). * P < 0.05, vs . sham group; # P < 0.05, vs . SCI group (one-way analysis of variance followed by the least significant difference test). IL-1β: Interleukin-1β; IL-6: interleukin-6; LiCl: lithium chloride; SCI: spinal cord injury; TNF-α: tumor necrosis factor-alpha.
Mouse Il 1 Beta/Il 1f2 Antibody, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+monoclonal+anti+il+1%CE%B2+antibody/Mouse+IL-1+beta%2FIL-1F2+Antibody/custom%40mab401%4034115964
Average 93 stars, based on 1 article reviews
mouse il-1 beta/il-1f2 antibody - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier
arnt/hif-1 beta antibody (h1beta234) - bsa free  (Bio-Techne corporation)
94
Bio-Techne corporation arnt/hif-1 beta antibody (h1beta234) - bsa free
Lithium suppresses activation of inflammatory cytokines in the spinal cord of rats with SCI . Sham group: No spinal cord injury or treatment; SCI group: spinal cord injury only; LiCl group: lithium treatment after spinal cord injury. <t>(A–C)</t> <t>TNF-α</t> (A), IL-1β (B), and IL-6 (C) expression in the spinal cord were detected by enzyme-linked immunosorbent assay. (D) Representative immunohistochemical staining for IL-1β 7 days after surgery. The number of IL-1β-positive cells was higher in the LiCl group than in the sham group, but lower than in the SCI group. Black arrows indicate IL-1β-positive cells. Scale bars: 50 μm. (E) Quantification of IL-1β-positive cells 7 days after surgery. (F, <t>G)</t> <t>TNF-α,</t> IL-1β, and IL-6 expression. Data are shown as mean ± SD ( n = 6). * P < 0.05, vs . sham group; # P < 0.05, vs . SCI group (one-way analysis of variance followed by the least significant difference test). IL-1β: Interleukin-1β; IL-6: interleukin-6; LiCl: lithium chloride; SCI: spinal cord injury; TNF-α: tumor necrosis factor-alpha.
Arnt/Hif 1 Beta Antibody (H1beta234) Bsa Free, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+monoclonal+anti+il+1%CE%B2+antibody/ARNT%2FHIF-1+beta+Antibody+(H1beta234)+-+BSA+Free/custom%40nb100-124%4034592152
Average 94 stars, based on 1 article reviews
arnt/hif-1 beta antibody (h1beta234) - bsa free - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier
anti-il-1β: mouse il-1beta antibody  (Cell Applications Inc)
N/A
BACKGROUND Interleukin-1 (IL-1) is the prototypic pro-inflammatory cytokine produced predominantly by activated monocytes and macrophages. There are two forms of IL-1, IL-1alpha and IL-1beta and in most studies, their biological activities are indistinguishable. IL-1beta is
   Buy from Supplier

Image Search Results


Lithium suppresses activation of inflammatory cytokines in the spinal cord of rats with SCI . Sham group: No spinal cord injury or treatment; SCI group: spinal cord injury only; LiCl group: lithium treatment after spinal cord injury. (A–C) TNF-α (A), IL-1β (B), and IL-6 (C) expression in the spinal cord were detected by enzyme-linked immunosorbent assay. (D) Representative immunohistochemical staining for IL-1β 7 days after surgery. The number of IL-1β-positive cells was higher in the LiCl group than in the sham group, but lower than in the SCI group. Black arrows indicate IL-1β-positive cells. Scale bars: 50 μm. (E) Quantification of IL-1β-positive cells 7 days after surgery. (F, G) TNF-α, IL-1β, and IL-6 expression. Data are shown as mean ± SD ( n = 6). * P < 0.05, vs . sham group; # P < 0.05, vs . SCI group (one-way analysis of variance followed by the least significant difference test). IL-1β: Interleukin-1β; IL-6: interleukin-6; LiCl: lithium chloride; SCI: spinal cord injury; TNF-α: tumor necrosis factor-alpha.

Journal: Neural Regeneration Research

Article Title: Lithium promotes recovery after spinal cord injury

doi: 10.4103/1673-5374.327348

Figure Lengend Snippet: Lithium suppresses activation of inflammatory cytokines in the spinal cord of rats with SCI . Sham group: No spinal cord injury or treatment; SCI group: spinal cord injury only; LiCl group: lithium treatment after spinal cord injury. (A–C) TNF-α (A), IL-1β (B), and IL-6 (C) expression in the spinal cord were detected by enzyme-linked immunosorbent assay. (D) Representative immunohistochemical staining for IL-1β 7 days after surgery. The number of IL-1β-positive cells was higher in the LiCl group than in the sham group, but lower than in the SCI group. Black arrows indicate IL-1β-positive cells. Scale bars: 50 μm. (E) Quantification of IL-1β-positive cells 7 days after surgery. (F, G) TNF-α, IL-1β, and IL-6 expression. Data are shown as mean ± SD ( n = 6). * P < 0.05, vs . sham group; # P < 0.05, vs . SCI group (one-way analysis of variance followed by the least significant difference test). IL-1β: Interleukin-1β; IL-6: interleukin-6; LiCl: lithium chloride; SCI: spinal cord injury; TNF-α: tumor necrosis factor-alpha.

Article Snippet: Subsequently, the membranes were incubated overnight at 4°C with rat monoclonal primary antibodies against IL-6 (1:1000, Acris Antibodies GmbH, Herford, Germany; Cat# SM1695PX, RRID:AB_1004115), IL-1β (1:100, Miltenyi Biotec, Bergisch Gladbach, Germany; Cat# 130-125-220, RRID:AB_2889697), TNF-α (1:100, Miltenyi Biotec; Cat# 130-102-386, RRID:AB_2661141), NLRP3 (1:1000, MyBioSource, San Diego, CA, USA; Cat# MBS604215, RRID:AB_10911109), ASC (1:2000, Gabriel Núñez, University of Michigan, Ann Arbor, MI, USA; Cat# GN-ASC, RRID:AB_2750645), pro-Caspase-1 (1:1000, ProSci, San Diego, CA, USA; Cat# 48-495, RRID:AB_1945485), Caspase-1 (1:1000, Acris Antibodies GmbH; Cat# AP06610PU-N, RRID:AB_1611115), GSDMD (1:100, Thermo Fisher Scientific; Cat# A305-736A-M, RRID:AB_2782894), and IL-18 (1:100, DSHB, Iowa City, IA, USA; Cat# CPTC-IL18-2, RRID:AB_1553716), followed by incubation with horseradish peroxidase-conjugated rabbit anti-rat IgG (1:1000, Biorbyt, Cat# orb21564, RRID:AB_10932535) at 20°C for 1 hour, and finally stained with a diaminobenzidine solution.

Techniques: Activation Assay, Expressing, Enzyme-linked Immunosorbent Assay, Immunohistochemical staining, Staining

Lithium attenuates inflammatory, oxidative, and pyroptotic injury in PC12 cells subjected to OGD . Con group: untreated PC12 cells; OGD group: PC12 cells subjected to OGD; OGD + LiCl group: PC12 cells subjected to OGD and treated with LiCl; OGD + LiCl + ATRA group: PC12 cells subjected to OGD and treated with LiCl and the Nrf2 inhibitor ATRA. (A–I) TNF-α (A), IL-1β (B), IL-6 (C), CAT (D), GSH-Px (E), LDH (F), SOD (G), MDA (H), and T-AOC (I) expression as detected by ELISA. (J–N) Flow cytometry analysis of the percentage of pyroptotic PC12 cells. Data are shown as mean ± SD ( n = 6). * P < 0.05, vs . control group; # P < 0.05, vs . OGD group; & P < 0.05, vs . OGD + LiCl group (one-way analysis of variance followed by least significant difference test). ATRA: All-trans retinoic acid; CAT: catalase; Con: control; GSH-Px: glutathione peroxidase; IL-1β: interleukin-1β; IL-6: interleukin-6; LiCl: lithium chloride; LPO: lipid peroxide; MDA: malondialdehyde; OGD: oxygen glucose deprivation; SOD: superoxide dismutase; T-AOC: total antioxidant capacity; TNF-α: tumor necrosis factor-alpha.

Journal: Neural Regeneration Research

Article Title: Lithium promotes recovery after spinal cord injury

doi: 10.4103/1673-5374.327348

Figure Lengend Snippet: Lithium attenuates inflammatory, oxidative, and pyroptotic injury in PC12 cells subjected to OGD . Con group: untreated PC12 cells; OGD group: PC12 cells subjected to OGD; OGD + LiCl group: PC12 cells subjected to OGD and treated with LiCl; OGD + LiCl + ATRA group: PC12 cells subjected to OGD and treated with LiCl and the Nrf2 inhibitor ATRA. (A–I) TNF-α (A), IL-1β (B), IL-6 (C), CAT (D), GSH-Px (E), LDH (F), SOD (G), MDA (H), and T-AOC (I) expression as detected by ELISA. (J–N) Flow cytometry analysis of the percentage of pyroptotic PC12 cells. Data are shown as mean ± SD ( n = 6). * P < 0.05, vs . control group; # P < 0.05, vs . OGD group; & P < 0.05, vs . OGD + LiCl group (one-way analysis of variance followed by least significant difference test). ATRA: All-trans retinoic acid; CAT: catalase; Con: control; GSH-Px: glutathione peroxidase; IL-1β: interleukin-1β; IL-6: interleukin-6; LiCl: lithium chloride; LPO: lipid peroxide; MDA: malondialdehyde; OGD: oxygen glucose deprivation; SOD: superoxide dismutase; T-AOC: total antioxidant capacity; TNF-α: tumor necrosis factor-alpha.

Article Snippet: Subsequently, the membranes were incubated overnight at 4°C with rat monoclonal primary antibodies against IL-6 (1:1000, Acris Antibodies GmbH, Herford, Germany; Cat# SM1695PX, RRID:AB_1004115), IL-1β (1:100, Miltenyi Biotec, Bergisch Gladbach, Germany; Cat# 130-125-220, RRID:AB_2889697), TNF-α (1:100, Miltenyi Biotec; Cat# 130-102-386, RRID:AB_2661141), NLRP3 (1:1000, MyBioSource, San Diego, CA, USA; Cat# MBS604215, RRID:AB_10911109), ASC (1:2000, Gabriel Núñez, University of Michigan, Ann Arbor, MI, USA; Cat# GN-ASC, RRID:AB_2750645), pro-Caspase-1 (1:1000, ProSci, San Diego, CA, USA; Cat# 48-495, RRID:AB_1945485), Caspase-1 (1:1000, Acris Antibodies GmbH; Cat# AP06610PU-N, RRID:AB_1611115), GSDMD (1:100, Thermo Fisher Scientific; Cat# A305-736A-M, RRID:AB_2782894), and IL-18 (1:100, DSHB, Iowa City, IA, USA; Cat# CPTC-IL18-2, RRID:AB_1553716), followed by incubation with horseradish peroxidase-conjugated rabbit anti-rat IgG (1:1000, Biorbyt, Cat# orb21564, RRID:AB_10932535) at 20°C for 1 hour, and finally stained with a diaminobenzidine solution.

Techniques: Expressing, Enzyme-linked Immunosorbent Assay, Flow Cytometry, Control